DK1845966T3 - Farmaceutisk sammensætning til anvendelse i behandlingen eller forebyggelsen af neoplastiske sygdomme - Google Patents
Farmaceutisk sammensætning til anvendelse i behandlingen eller forebyggelsen af neoplastiske sygdommeInfo
- Publication number
- DK1845966T3 DK1845966T3 DK06700207.1T DK06700207T DK1845966T3 DK 1845966 T3 DK1845966 T3 DK 1845966T3 DK 06700207 T DK06700207 T DK 06700207T DK 1845966 T3 DK1845966 T3 DK 1845966T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- treatment
- pharmaceutical composition
- glutamine
- alpha
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001613 neoplastic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 abstract 5
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 229930195712 glutamate Natural products 0.000 abstract 3
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 abstract 2
- 229960003104 ornithine Drugs 0.000 abstract 2
- 108010016626 Dipeptides Proteins 0.000 abstract 1
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL372183A PL372183A1 (pl) | 2005-01-11 | 2005-01-11 | Preparat przeciwnowotworowy oraz zastosowanie preparatu przeciwnowotworowego |
| PCT/PL2006/000003 WO2006075924A1 (en) | 2005-01-11 | 2006-01-10 | Antineoplastic preparation and the use of antineoplastic preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1845966T3 true DK1845966T3 (da) | 2010-11-08 |
Family
ID=36168380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06700207.1T DK1845966T3 (da) | 2005-01-11 | 2006-01-10 | Farmaceutisk sammensætning til anvendelse i behandlingen eller forebyggelsen af neoplastiske sygdomme |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7759396B2 (da) |
| EP (1) | EP1845966B1 (da) |
| JP (2) | JP2008526838A (da) |
| CN (1) | CN101111241B (da) |
| AT (1) | ATE474570T1 (da) |
| AU (1) | AU2006205279B2 (da) |
| CA (1) | CA2593780C (da) |
| DE (1) | DE602006015608D1 (da) |
| DK (1) | DK1845966T3 (da) |
| ES (1) | ES2349233T3 (da) |
| PL (2) | PL372183A1 (da) |
| WO (1) | WO2006075924A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2033623A1 (en) | 2007-09-07 | 2009-03-11 | Cutech S.R.L. | Compositions comprising ornithine ketoglutarate (OKG) |
| CN113082009A (zh) * | 2014-02-12 | 2021-07-09 | 加利福尼亚大学董事会 | 用于治疗衰老和与年龄相关的疾病和症状的组合物和方法 |
| WO2025263592A1 (ja) * | 2024-06-19 | 2025-12-26 | Ａｇｃ株式会社 | グルタミン代謝阻害剤 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT393221B (de) * | 1988-02-03 | 1991-09-10 | Leopold Pharma Gmbh | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken |
| FR2775901B1 (fr) * | 1998-03-13 | 2000-07-21 | Logeais Labor Jacques | Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments |
| SE0201713D0 (sv) * | 2001-11-23 | 2002-06-06 | Gramineer Internat Ab | New methods and use III |
| NZ538405A (en) | 2002-08-01 | 2007-12-21 | Aesgen Inc | Improved treatment of cancer with glutamine and carbohydrate |
| AT412447B (de) * | 2002-11-27 | 2005-03-25 | C Y L Handelsges M B H | Mittel mit zerstörender wirkung auf maligne tumore sowie verfahren zu seiner herstellung |
| PT1534305E (pt) * | 2003-05-07 | 2007-02-28 | Osteologix As | Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis |
| US20050124684A1 (en) * | 2003-08-29 | 2005-06-09 | Ying Du | 5-(hydroxymethyl) furfural and derivatives as inhibitors of TNFalpha and IL-1beta production |
| ES2510690T3 (es) | 2004-12-17 | 2014-10-21 | Alan B. Cash | Método para extender la esperanza de vida y retrasar la aparición de enfermedad relacionada con la edad |
-
2005
- 2005-01-11 PL PL372183A patent/PL372183A1/pl not_active Application Discontinuation
-
2006
- 2006-01-10 EP EP06700207A patent/EP1845966B1/en not_active Expired - Lifetime
- 2006-01-10 DE DE602006015608T patent/DE602006015608D1/de not_active Expired - Lifetime
- 2006-01-10 DK DK06700207.1T patent/DK1845966T3/da active
- 2006-01-10 US US11/813,526 patent/US7759396B2/en not_active Expired - Fee Related
- 2006-01-10 AT AT06700207T patent/ATE474570T1/de not_active IP Right Cessation
- 2006-01-10 CA CA2593780A patent/CA2593780C/en not_active Expired - Fee Related
- 2006-01-10 AU AU2006205279A patent/AU2006205279B2/en not_active Ceased
- 2006-01-10 JP JP2007550321A patent/JP2008526838A/ja not_active Ceased
- 2006-01-10 ES ES06700207T patent/ES2349233T3/es not_active Expired - Lifetime
- 2006-01-10 WO PCT/PL2006/000003 patent/WO2006075924A1/en not_active Ceased
- 2006-01-10 CN CN2006800019675A patent/CN101111241B/zh not_active Expired - Fee Related
- 2006-01-10 PL PL06700207T patent/PL1845966T3/pl unknown
-
2012
- 2012-10-01 JP JP2012219701A patent/JP2013035864A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006205279A1 (en) | 2006-07-20 |
| US7759396B2 (en) | 2010-07-20 |
| CN101111241B (zh) | 2010-12-01 |
| CA2593780A1 (en) | 2006-07-20 |
| WO2006075924A1 (en) | 2006-07-20 |
| PL372183A1 (pl) | 2006-07-24 |
| CA2593780C (en) | 2013-11-26 |
| US20080058422A1 (en) | 2008-03-06 |
| JP2013035864A (ja) | 2013-02-21 |
| ATE474570T1 (de) | 2010-08-15 |
| ES2349233T3 (es) | 2010-12-29 |
| CN101111241A (zh) | 2008-01-23 |
| AU2006205279B2 (en) | 2011-05-26 |
| EP1845966B1 (en) | 2010-07-21 |
| JP2008526838A (ja) | 2008-07-24 |
| EP1845966A1 (en) | 2007-10-24 |
| DE602006015608D1 (de) | 2010-09-02 |
| PL1845966T3 (pl) | 2011-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN07452A1 (en) | Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine | |
| EP2584043A3 (en) | Anti-glypican 3 antibody having improved kinetics in plasma | |
| SE1651735A1 (en) | Substances for treatment of fatty liver-related conditions | |
| MX341883B (es) | Composicion farmaceutica para el tratamiento y prevencion de canceres. | |
| TW200634051A (en) | Processes for preparing a polypeptide | |
| CO6290629A2 (es) | Composiciones de limpieza de amino ácido básico y métodos | |
| ZA200707508B (en) | 2-[isoquinolin-3-carbonyl) amino] -propionic acid derivatives as inhibitors of factors XI and IX for the treatment of thrombosis | |
| BRPI0606301A2 (pt) | processo para fabricar uma mistura de sais de acetato de polipeptìdeos, processo para fabricar uma mistura de sais de polipeptìdeos de trifluoroacetila não protegidos, mistura de sais de acetato de polipeptìdeos, composição farmacêutica, processos para a preparação de uma composição farmacêutica, e, mistura de polipeptìdeos de trifluoroacetila protegidos | |
| WO2010051541A3 (en) | Compositions containing delta-9-thc-amino acid esters and process of preparation | |
| WO2008053297A3 (en) | Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa | |
| AU2008267058A8 (en) | Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine | |
| ZA201005615B (en) | Pharmaceutical compositions of entacapone,levodopa and carbidopa with improved bioavailability | |
| WO2008099874A1 (ja) | ピラジン誘導体を含有する医薬組成物およびピラジン誘導体を組み合わせて使用する方法 | |
| DK1583430T3 (da) | Fremgangsmåde til fremstilling af en sammensætning til supplement til dyr med oplösninger af essentielle aminosyremetalkomplekser | |
| DK1290011T3 (da) | Melphalan-derivater og deres anvendelse som cancer-kemoterapeutiske lægemidler | |
| UY27618A1 (es) | Ésteres hidroxamato de ácido n-(4-fenil-sustituido)-antranílico | |
| WO2006062424A3 (en) | Use of 3-hydroxy-3-methylbutyrate alone or in combination with alpha-ketoglutarate in the growth and mineralisation of the osteo-skeletal system | |
| BRPI0703970A2 (pt) | tratamento de pacientes psiquiátricos com função hepática reduzida com paliperidona | |
| TNSN07228A1 (en) | Manufacture process of organic compounds | |
| PL1845966T3 (pl) | Farmaceutyczny preparat do zastosowania w leczeniu lub profilaktyce chorób nowotworowych | |
| ATE540679T1 (de) | Verfahren zur verringerung der gastrointestinalen toxizität durch verabreichung von tegafur | |
| TNSN07229A1 (en) | Manufacture process of n-substituted salicylamides | |
| MXPA05006408A (es) | Derivados deuterizados de catecolamina y medicamentos comprendiendo estos compuestos. | |
| ATE536342T1 (de) | Neue carbamoylglycinderivate | |
| EP1774966A4 (en) | MEANS TO INHIBIT THE USE AND PROGRESS OF LIVER CANCER IN PATIENTS WITH HEPATITIS C-VIRUS POSITIVE LIVER CIRR |